Biosensors International Group has announced that a drug-eluting stent developed by the company has demonstrated equal safety and efficacy as compared to Johnson & Johnson’s drug-eluting stent, Cypher Select, based upon nine-month clinical and angiographic follow-up data.
No Pingbacks for this post yet...
The healthcare industry is an ever-changing, ever-adapting environment. MET can help you ensure you are kept up to date by providing you with the latest industry news.
| Mon | Tue | Wed | Thu | Fri | Sat | Sun |
|---|---|---|---|---|---|---|
| << < | > >> | |||||
| 1 | 2 | 3 | 4 | 5 | ||
| 6 | 7 | 8 | 9 | 10 | 11 | 12 |
| 13 | 14 | 15 | 16 | 17 | 18 | 19 |
| 20 | 21 | 22 | 23 | 24 | 25 | 26 |
| 27 | 28 | 29 | 30 | |||